FDA Investigator Edwin Martinez
Edwin Martinez has inspections in 4 countries as of 20 Sep 2023. Edwin Martinez has collaborated with a combinined 2596 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
25
Last Inspection Date:
20 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
India,
China
Co-Investigator(s):
Adalberto Cajigas,
Adaliz Santaliz Cruz,
Alan P Kurtzberg,
Alberto A Viciedo,
Anita Narula, PhD,
Ann L Demarco,
Annette Melendez,
Anthony A Charity,
Ariel Cruz Figueroa,
Arlene M Badillo,
Arsen Karapetyan,
Barbara Janine Breithaupt,
Bonita S Chester,
Brenda Rivera,
Carla A Norris,
Carlos A Medina,
CDR Ileana Barreto Pettit,
CDR Thomas R Berry, PPh,
Charles I Ann,
Charles M Edwards,
Chelsea N Sealey,
Cheryl A Clausen,
Christina A Miller,
Claire M Minden,
Dana M Klimavicz,
Dayna I Martinez,
Dewayne E Whitlock,
Djamila Harouaka,
Eric S Weilage,
Felix Maldonado,
Frances L Dejesus,
Gam S Zamil,
German Rivera,
Gwyn G Dickinson,
Hector J Colon Torres,
Iraida Ortiz,
Israel Santiago, OCM,
Ivis L Negron,
Ivis Lnegron Torres,
James C Maclaughlin,
James S Cartwright,
Jason F Chancey,
Javier O Vega,
Jeffrey P Raimondi,
Jennifer A Quinones,
Jogy George,
John A Gonzalez,
Jorge E Martinez,
Jorge L Guadalupe,
Jorge L Lajara,
Jose A Cruz,
Jose A Moreno,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
José E Meléndez,
Jose E Melendez, DDC,
Jose Lpez,
Jose M Cayuela,
Jose Perez Soto,
Jose R Lopez,
Jose Velez,
Juan Rjimenez Garcia,
Karl D Hezel,
Kent C Faul,
Krishna Ghosh, PhD,
Laiza V Garcia,
Lareese K Thomas,
Lata C Mathew, PhD,
Laura E Garcia,
Lauren N Howard,
Laurimer Kuilan Torres,
Libia M Lugo,
Lisa M Lopez,
Lourdes Andujar,
LT Rafael Gonzalez,
Luis Soto Lopez,
Marian E Ramirez,
Marianela Aponte,
Marianela Aponte Cruz,
Marijo B Kambere, PhD,
Marlene Rodriguez Colon,
Martin K Yan, PhD,
Martin Yan,
Mary E Storch,
Michael R Goga,
Michael R Klapal,
Michelle Y Clark Stuart,
Miguel A Martinez,
Miguel Hernandez Sanchez,
Milva E Melendez,
Min Tang,
Minerva Rogers,
Muralidhara B Gavini, PhD,
Myriam M Sosa,
Nancy Rosado,
Nebil A Oumer,
Nicole E Knowlton,
Nilufer M Tampal, PhD,
Nilufer M Tampalm, PhD,
Noreen Muniz,
Pablo Feliciano,
Patrick C Klotzbuecher,
Patrick L Wisor,
Peter E Baker,
Pratik S Upadhyay, DDC,
Rafael E Cruz,
Rafael Nevarez,
Rafael Nevarez Nieves,
Ramon A Hernandez,
Rapti D Madurawe,
Raquel Gonzalez,
Raquel Gonzalez Rivera,
Raymond T Oji,
Rebeca M Melendez,
Rebecca Parrilla,
Rebecca Rodriguez,
Regina T Brown,
Robert J Martin,
Rochelle L Cross,
Russell K Riley,
Santos E Camara,
Sarah E Mcmullen,
Sarah Forney,
Sixto M Mercado Rios,
Sonia M Monges,
Sony Mathews,
Sriram Susrambraham,
State Agency,
Stephen J Mottola,
Steven B Barber,
Susan F Laska, MS,
Temar Q Williams,
Thomas J Arista,
Truong Xuan Nguyen (Andy),
Ucheabuchi C Chudi Nwankwor,
Victor S Pacheco,
Vilmary Negron Rodriguez,
Wanda J Torres,
Ying Zhang,
Yvette I Henry,
Yvette I Johnson,
Zhao Wang, PhD,
Zhongren Wu
Edwin Martinez's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| October, 2012 | FDA 483 | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe - Form 483, 2012-10-22 |
| February, 2005 | EIR | McNeil Healthcare LLC. - EIR, 2005-02-23 |
| April, 2002 | EIR | Wyeth Pharmaceuticals Company - EIR, 2002-04-04 |
| November, 2002 | EIR | Neopharm Labs Inc. - EIR, 2005-03-25 |
| April, 2002 | FDA 483 | Wyeth Pharmaceuticals Company - Form 483, 2002-04-04 |
| September, 2007 | FDA 483 | Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2007-09-07 |
| March, 2017 | FDA 483 | Ex-Lax, Inc. - Form 483, 2017-03-31 |
| February, 2005 | FDA 483 | McNeil Healthcare LLC. - Form 483, 2005-02-23 |
| October, 2012 | EIR | Caribe Holdings (Cayman) Co. Ltd. dba PuraCap Caribe - EIR, 2012-10-22 |
| August, 2009 | FDA 483 | Agropharma Laboratories Inc. - Form 483, 2009-08-19 |
| February, 2004 | EIR | Knoll LLC - EIR, 2004-02-06 |
| February, 2004 | FDA 483 | Knoll LLC - Form 483, 2004-02-06 |
| June, 2009 | FDA 483 | Wyeth Parenterals Divison of Wyeth Holdings Corp. - Form 483, 2009-06-29 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more